Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Scilex Holding (NASDAQ:SCLX) through any online brokerage.
Other companies in Scilex Holding’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Scilex Holding has a consensus price target of $396.67.
The stock price for Scilex Holding (NASDAQ: SCLX) is $2.6156 last updated October 20, 2026 at 4:05 PM EDT.
There are no upcoming dividends for Scilex Holding.
Scilex Holding does not have any upcoming earnings scheduled.
There is no upcoming split for Scilex Holding.
Scilex Holding is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.